- Home
- GAME vs STRO Comparison
GAME vs STRO Comparison
Compare GAME & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAME
- STRO
- Stock Information
- Founded
- GAME 2011
- STRO 2003
- Country
- GAME United States
- STRO United States
- Employees
- GAME N/A
- STRO N/A
- Industry
- GAME
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GAME
- STRO Health Care
- Exchange
- GAME Nasdaq
- STRO Nasdaq
- Market Cap
- GAME 66.6M
- STRO 76.5M
- IPO Year
- GAME 2009
- STRO 2018
- Fundamental
- Price
- GAME $0.81
- STRO $0.85
- Analyst Decision
- GAME Strong Buy
- STRO Hold
- Analyst Count
- GAME 2
- STRO 7
- Target Price
- GAME $3.00
- STRO $1.97
- AVG Volume (30 Days)
- GAME 3.1M
- STRO 450.6K
- Earning Date
- GAME 11-13-2025
- STRO 11-12-2025
- Dividend Yield
- GAME N/A
- STRO N/A
- EPS Growth
- GAME N/A
- STRO N/A
- EPS
- GAME N/A
- STRO N/A
- Revenue
- GAME $93,375,339.00
- STRO $104,473,000.00
- Revenue This Year
- GAME $2.32
- STRO $65.48
- Revenue Next Year
- GAME $26.42
- STRO N/A
- P/E Ratio
- GAME N/A
- STRO N/A
- Revenue Growth
- GAME 54.19
- STRO N/A
- 52 Week Low
- GAME $0.50
- STRO $0.52
- 52 Week High
- GAME $2.87
- STRO $4.60
- Technical
- Relative Strength Index (RSI)
- GAME 55.33
- STRO 45.34
- Support Level
- GAME $0.77
- STRO $0.84
- Resistance Level
- GAME $0.86
- STRO $0.95
- Average True Range (ATR)
- GAME 0.04
- STRO 0.06
- MACD
- GAME 0.02
- STRO -0.01
- Stochastic Oscillator
- GAME 76.84
- STRO 19.04
About GAME GameSquare Holdings Inc.
GameSquare Holdings Inc is engaged in revolutionizing the way brands and game publishers connect with hard-to-reach Gen Z, Gen Alpha, and Millennial audiences. It's next generation media, entertainment, and technology helps creators and maximize their brand partners' return on investment. Its purpose-built platform provides marketing and creative services, offers data and analytics solutions, and amplifies awareness through FaZe Clan.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.